IRIS Accounts Production v24.2.0.383 10614846 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false A Ordinary 1.00000 B Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh106148462023-03-31106148462024-03-31106148462023-04-012024-03-31106148462022-03-31106148462022-04-012023-03-31106148462023-03-3110614846ns15:EnglandWales2023-04-012024-03-3110614846ns14:PoundSterling2023-04-012024-03-3110614846ns10:Director12023-04-012024-03-3110614846ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3110614846ns10:SmallEntities2023-04-012024-03-3110614846ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3110614846ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3110614846ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3110614846ns10:FullAccounts2023-04-012024-03-3110614846ns10:OrdinaryShareClass12023-04-012024-03-3110614846ns10:OrdinaryShareClass22023-04-012024-03-3110614846ns10:Director22023-04-012024-03-3110614846ns10:Director32023-04-012024-03-3110614846ns10:Director42023-04-012024-03-3110614846ns10:RegisteredOffice2023-04-012024-03-3110614846ns5:CurrentFinancialInstruments2024-03-3110614846ns5:CurrentFinancialInstruments2023-03-3110614846ns5:ShareCapital2024-03-3110614846ns5:ShareCapital2023-03-3110614846ns5:RetainedEarningsAccumulatedLosses2024-03-3110614846ns5:RetainedEarningsAccumulatedLosses2023-03-3110614846ns5:FurnitureFittings2023-04-012024-03-3110614846ns5:ComputerEquipment2023-04-012024-03-3110614846ns5:FurnitureFittings2023-03-3110614846ns5:ComputerEquipment2023-03-3110614846ns5:FurnitureFittings2024-03-3110614846ns5:ComputerEquipment2024-03-3110614846ns5:FurnitureFittings2023-03-3110614846ns5:ComputerEquipment2023-03-3110614846ns5:CostValuation2023-03-3110614846ns5:AdditionsToInvestments2024-03-3110614846ns5:RevaluationsIncreaseDecreaseInInvestments2024-03-3110614846ns5:CostValuation2024-03-3110614846ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3110614846ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3110614846ns10:OrdinaryShareClass12024-03-3110614846ns10:OrdinaryShareClass22024-03-31106148461ns10:Director12023-03-31106148461ns10:Director12022-03-31106148461ns10:Director12023-04-012024-03-31106148461ns10:Director12022-04-012023-03-31106148461ns10:Director12024-03-31106148461ns10:Director12023-03-31
REGISTERED NUMBER: 10614846 (England and Wales)









MARK HEALTHCARE PRIVATE LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024






MARK HEALTHCARE PRIVATE LTD (REGISTERED NUMBER: 10614846)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MARK HEALTHCARE PRIVATE LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Dr R R Mandala
Dr K Talari
M Mandala
A Mandala





REGISTERED OFFICE: 150 Buckswood Drive
Crawley
West Sussex
RH11 8JF





REGISTERED NUMBER: 10614846 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

MARK HEALTHCARE PRIVATE LTD (REGISTERED NUMBER: 10614846)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,274 3,216
Investments 5 102,524 67,214
105,798 70,430

CURRENT ASSETS
Debtors 6 8,994 4,509
Cash at bank 21,505 14,046
30,499 18,555
CREDITORS
Amounts falling due within one year 7 10,442 6,681
NET CURRENT ASSETS 20,057 11,874
TOTAL ASSETS LESS CURRENT
LIABILITIES

125,855

82,304

PROVISIONS FOR LIABILITIES 5,487 2,457
NET ASSETS 120,368 79,847

CAPITAL AND RESERVES
Called up share capital 8 150 150
Retained earnings 120,218 79,697
SHAREHOLDERS' FUNDS 120,368 79,847

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MARK HEALTHCARE PRIVATE LTD (REGISTERED NUMBER: 10614846)

BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 August 2024 and were signed on its behalf by:





Dr R R Mandala - Director


MARK HEALTHCARE PRIVATE LTD (REGISTERED NUMBER: 10614846)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

Mark Healthcare Private Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on cost
Computer equipment - 33% on cost

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MARK HEALTHCARE PRIVATE LTD (REGISTERED NUMBER: 10614846)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 April 2023 2,270 5,767 8,037
Additions - 2,129 2,129
At 31 March 2024 2,270 7,896 10,166
DEPRECIATION
At 1 April 2023 908 3,913 4,821
Charge for year 454 1,617 2,071
At 31 March 2024 1,362 5,530 6,892
NET BOOK VALUE
At 31 March 2024 908 2,366 3,274
At 31 March 2023 1,362 1,854 3,216

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 April 2023 67,214
Additions 24,000
Revaluations 11,310
At 31 March 2024 102,524
NET BOOK VALUE
At 31 March 2024 102,524
At 31 March 2023 67,214

MARK HEALTHCARE PRIVATE LTD (REGISTERED NUMBER: 10614846)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

5. FIXED ASSET INVESTMENTS - continued

Cost or valuation at 31 March 2024 is represented by:

Other
investments
£   
Valuation in 2019 294
Valuation in 2020 (795 )
Valuation in 2021 5,979
Valuation in 2022 2,676
Valuation in 2023 1,560
Valuation in 2024 11,310
Cost 81,500
102,524

If fixed asset investments had not been revalued they would have been included at the following historical cost:

2024 2023
£    £   
Cost 57,500 57,500

Fixed asset investments were valued on an open market basis on 31 March 2024 by third party investors .

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 1,494 4,509
Other debtors 7,500 -
8,994 4,509

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 8,552 1,383
Other creditors 1,890 5,298
10,442 6,681

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 A Ordinary £1 100 100
50 B Ordinary £1 50 50
150 150

MARK HEALTHCARE PRIVATE LTD (REGISTERED NUMBER: 10614846)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
Dr R R Mandala
Balance outstanding at start of year (3,463 ) 2,796
Amounts advanced 13,462 -
Amounts repaid (2,499 ) (6,259 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 7,500 (3,463 )